Related Experiment Video
Updated: Oct 1, 2025

07:44
In vivo Structural Assessments of Ocular Disease in Rodent Models using Optical Coherence Tomography
Published on: July 24, 2020
3.1K
Conjunctival optical coherence tomography angiography imaging in sickle cell maculopathy
Glory E Mgboji1, Dennis Cain1, Adrienne W Scott1
1Retina Division, Wilmer Eye Institute, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Baltimore, MD, 21287, USA.
American Journal of Ophthalmology Case Reports
|March 4, 2022
Summary
Optical coherence tomography angiography (OCTA) reveals reduced vascular density in the conjunctiva and macula of sickle cell anemia patients. This imaging technique highlights key vascular changes in sickle cell disease.
Area of Science:
- Ophthalmology
- Vascular Biology
- Hematology
Background:
- Sickle cell anemia (SCA) is a genetic blood disorder with significant ocular complications.
- Understanding the vascular manifestations in both the conjunctiva and macula is crucial for managing SCA patients.
Observation:
- Optical coherence tomography angiography (OCTA) was used to image the macula and conjunctiva in patients with SCA (HbSS and HbSC).
- Macular OCTA showed decreased vascular density, particularly in the deep capillary plexus.
- Conjunctival OCTA revealed reduced vascular density and flow voids, correlating with clinical findings.
Findings:
- OCTA effectively visualizes reduced vascular density in the conjunctiva and macula of SCA patients.
- A notable difference in vascular density was observed between the superficial and deep capillary plexuses in the macula.
- Conjunctival flow voids were prominent in SCA patients compared to controls.
Implications:
- OCTA provides high-resolution visualization of conjunctival abnormalities in SCA.
- Further research is needed to establish the role of conjunctival OCTA in SCA diagnosis and monitoring.
- Investigating the link between conjunctival and macular perfusion may offer new insights into SCA pathophysiology.
More Related Videos
Related Concept Videos
Angle Closure Glaucoma: Treatment
864
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
864
Glaucoma: Overview
938
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
938
Open Angle Glaucoma: Treatment
731
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
731

